Skip to main content
logo
Solvonis Therapeutics plc (LON:SVNS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.1405
+0.0055 (4.07%)
Aug 12, 2026, 11:00 AM GMT

Solvonis Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 May '21
Revenue
---0.590.540.52
Revenue Growth
---8.30%4.23%57.58%
Gross Profit
---0.260.30.49
Operating Income
-3.48-3.48-1.38-3.12-2.7-0.44
Net Income
-5.74-5.74-1.59-3.12-2.71-0.45
Earnings Per Share
-0.00-0.00-0.00-0.03-0.03-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 May '21
Cash & Investments
1.721.720.760.161.640.04
Total Debt
0.080.0800.030.020.65
Net Cash (Debt)
1.651.650.760.121.62-0.62
Net Cash Growth
0.18%117.30%525.62%-92.52%--
Net Cash Per Share
0.000.000.000.000.02-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 May '21
Operating Cash Flow
-3.27-3.27-1.13-1.24-2.36-0.17
Capital Expenditures
----0.22-0.72-0.02
Free Cash Flow
-3.27-3.27-1.13-1.45-3.08-0.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 May '21
Gross Margin
---43.95%55.35%94.23%
Operating Margin
----531.00%-498.34%-85.38%
Pretax Margin
----531.52%-499.08%-86.73%
Profit Margin
----531.52%-499.08%-86.73%
FCF Margin
----247.70%-567.90%-34.81%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 May '21
PS Ratio
---1.0226.57-